Frederick Health
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nebulized Heparin for the Treatment of COVID-19 (NCT04723563) | Frederick Health | 2021-02-22 |
| Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury (NCT04397510) | Frederick Health | 2020-06-01 |
Track Frederick Health automatically
Every clearance here is in the API, with alerts when new ones post.